Cube Labs
Investor · Rome, Italy · Europe
Cube Labs is an Italian venture builder in the healthcare technology sector that creates new companies from academic R&D and provides strategic, entrepreneurial and operational support across their life cycle. It became listed on the Milan Stock Exchange's Euronext Growth Milan - Pro Segment in March 2023.
Invests inHealthcare & Biotech
In its own wordshealthcarelife sciencesbiotechmedtechpharmaceuticalsventure builder
Your fit with Cube Labs
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsCube Labs lists 14 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (65%), AI & Machine Learning (12%) and Industrial & Manufacturing (12%). 88% of its companies are based in Italy.
No funding round on record names Cube Labs yet, so the figures come from its portfolio page.
Round figures show recent activity, not Cube Labs' whole history. Rounds on record name 0 companies; its own site lists 14. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 65% | 15% |
| AI & Machine Learning | 12% | 18% |
| Industrial & Manufacturing | 12% | 7% |
| Food & Agriculture | 6% | 3% |
| Media & Entertainment | 6% | 4% |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers14100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 36th | 14 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 90th | 65% in its largest sector |
| Reach | 42th | 2 countries |
Compare Cube Labs head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
14 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Bio Aurum develops innovative products at the intersection of medical technology, neuroscience and nutraceutical research. | Healthcare & Biotech | Portfolio page | ||
| Biodiapers develops intelligent and cleantech absorbent products for babies, women, and the elderly. | Healthcare & Biotech | Portfolio page | ||
| Cartilago develops disease-modifying, chondroprotective technologies to fight osteoarthritis and related pathologies using regenerative medicine. | Healthcare & Biotech | Portfolio page | ||
| The company develops technology for detection of micro and nanoplastics | Media & Entertainment | Portfolio page | ||
| DeepCyte predicts and explains how drugs cause toxicity, before they reach patients, using single-cell metabolomics and AI. | Healthcare & Biotech | Portfolio page | ||
| G-Gravity designs and operates permanent innovation infrastructure, connecting companies, institutions, and cities across Europe. | Industrial & ManufacturingAI & Machine Learning | Portfolio page | ||
| Hiperforming Research develops and applies artificial intelligence to various industries, including business and research. | AI & Machine LearningIndustrial & Manufacturing | Portfolio page | ||
| Lipovexa develops innovative, science-based solutions to support and restore metabolic regulation, leveraging both therapeutic molecules and natural bioactive compounds derived from Mediterranean agri-food-by-products. | Healthcare & BiotechFood & Agriculture | Portfolio page | ||
| Lumina NanoBiotech develops and advances point-of-care diagnostics technology for monitoring vital clinical biomarkers | Healthcare & Biotech | Portfolio page | ||
| Myrtoviva develops products using natural extracts, particularly from myrtle, for cosmetic and nutraceutical applications. | Healthcare & Biotech | Portfolio page | ||
| Orpha Biotech develops innovative solutions for the treatment of rare diseases | Healthcare & Biotech | Portfolio page | ||
| Regenerabioma is pioneering a novel approach to wound care by harnessing the potential of the microbiota | Healthcare & Biotech | Portfolio page | ||
| Rescue Code develops innovative solutions in interventional cardiology and emergency cardiac surgery. | Healthcare & Biotech | Portfolio page | ||
| Skin Plastic Lab develops cutting-edge MedTech solutions for diagnostics in plastic surgery and wound care. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- cube-labs.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 14
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Cube Labs' profile as data
Pull Cube Labs' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/cube-labs.com
# also
GET /v1/firms/cube-labs.com/portfolio
GET /v1/firms/cube-labs.com/coinvestors
GET /v1/firms/cube-labs.com/news